Status:
ACTIVE_NOT_RECRUITING
Patient Decision Aid for the Treatment of Actinic Keratosis
Lead Sponsor:
Maastricht University Medical Center
Collaborating Sponsors:
Catharina Ziekenhuis Eindhoven
Conditions:
Actinic Keratoses
Patient Decision Aid
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study evaluates whether a Patient Decision Aid for the field-directed treatment of actinic keratosis has an effect on shared decision making and patient satisfaction.
Detailed Description
Actinic keratosis is the most common epithelial precancerous lesion among the Caucasian race. With an increase in prevalence worldwide due to an aging population and rise of ultraviolet exposure actin...
Eligibility Criteria
Inclusion
- diagnosis actinic keratosis in MaastrichtUMC+ or CatharinaHospital, Eindhoven
- age \>18 years
Exclusion
- no knowledge of Dutch language
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT06008171
Start Date
November 1 2022
End Date
December 1 2025
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ellen Oyen
Maastricht, Netherlands